Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Magnetic Resonance Spectroscopy × Clear all

Sponsor

Conditions

Breast Neoplasms 23 Prostatic Neoplasms 21 Carcinoma, Non-Small-Cell Lung 13 Glioma 12 Neoplasm Metastasis 11 Lymphoma 10 Glioblastoma 10 Neuroblastoma 9 Lung Neoplasms 8 Carcinoma, Renal Cell 8 Brain Neoplasms 8 Medulloblastoma 7 Ovarian Neoplasms 6 Neoplasms 6 Multiple Myeloma 6 Lymphoma, Non-Hodgkin 6 Fallopian Tube Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Sarcoma 5 Rectal Neoplasms 5 Osteosarcoma 5 Neuroendocrine Tumors 5 Melanoma 5 Ependymoma 5 Central Nervous System Neoplasms 5 Wilms Tumor 4 Triple Negative Breast Neoplasms 4 Rhabdomyosarcoma 4 Rhabdoid Tumor 4

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡